Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.
BACKGROUND: The parasitic flatworm Schistosoma mansoni is a blood fluke that causes schistosomiasis. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control disease is a combination of drug treatment and im...
Saved in:
Main Authors: | Vicente P Martins (Author), Suellen B Morais (Author), Carina S Pinheiro (Author), Natan R G Assis (Author), Barbara C P Figueiredo (Author), Natasha D Ricci (Author), Juliana Alves-Silva (Author), Marcelo V Caliari (Author), Sergio C Oliveira (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.
by: Clarice Carvalho Alves, et al.
Published: (2015) -
Drug-induced exposure of Schistosoma mansoni antigens SmCD59a and SmKK7.
by: Natalie Reimers, et al.
Published: (2015) -
Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of the trematode-specific helminth defence molecules (HDMs).
by: Jenna Shiels, et al.
Published: (2020) -
Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes.
by: Geoffrey N Gobert, et al.
Published: (2010) -
SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni.
by: Jan Dvorák, et al.
Published: (2009)